# Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults

> **NCT05114486** · PHASE3 · COMPLETED · sponsor: **Eyenovia Inc.** · enrollment: 145 (actual)

## Conditions studied

- Presbyopia

## Interventions

- **COMBINATION_PRODUCT:** Pilocarpine Ophthalmic administered with the Optejet dispenser
- **COMBINATION_PRODUCT:** Placebo administered with the Optejet dispenser

## Key facts

- **NCT ID:** NCT05114486
- **Lead sponsor:** Eyenovia Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-03
- **Primary completion:** 2022-09-20
- **Final completion:** 2022-09-20
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2023-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05114486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05114486, "Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05114486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*